VGX-0111

N/A

Report date: 2024/11/13 16:11:33

Base Information

Drug NameVGX-0111
Drug Alias NameVGX-0111
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionELOVL2 gene transference
TargetsVery long chain fatty acid elongase 2
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVisgenx Inc
China Registration ClassN/A

Develop Information

Active CompaniesVisgenx Inc
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A